Get a free sample of Gout Therapeutics Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Gout Therapeutics Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Gout Therapeutics Market Size
Gout Theapeutics Market size was valued at around USD 2.6 billion in 2023 and is estimated to grow at 7.3% CAGR from 2024 to 2032. Gout therapeutics involves medications and treatments used to manage and treat gout, a type of inflammatory arthritis characterized by sudden, severe attacks of pain, redness, and tenderness in the joints, often affecting the big toe. The condition is caused by the accumulation of urate crystals in the joint, due to high levels of uric acid in the blood.
The rising incidence of gout is a significant driver for the market. For instance, according to a study published by National Center for Biotechnology Information in March 2024, the global incidence of gout in individuals aged 15–39 years was 145.19 per 100,000 population in 2019, that doubled in comparison to 1990. This underscores the growing demand for effective treatment options in the gout therapeutics market.
Furthermore, advancements in treatment options, rising awareness towards early gout diagnosis, rising geriatric population, and changes in diet and lifestyle are the promoting factors advancing the growth of the market.
Why is the demand for non-steroidal anti-inflammatory gout therapeutics drugs rising?
The non-steroidal anti-inflammatory drugs segment of the gout therapeutics is forecasted to reach USD 1.7 billion by 2032, as they offer quick onset of action, often providing significant pain relief
How much is the gout therapeutics industry worth?
The gout therapeutics market size was valued at USD 2.6 billion in 2023 and is estimated to grow at 7.3% CAGR from 2024 to 2032, driven by the rising incidence of gout.
Why is the gout therapeutics industry growing in the U.S?
U.S. gout therapeutics market size is projected to reach USD 1.8 billion by 2032, owing to the robust healthcare infrastructure.
Who are the major gout therapeutics industry players?
Abbvie Inc, Amgen Inc, Boehringer Ingelheim International GmbH, GSK plc, Merck & Co., Inc, Novartis AG, and Pfizer Inc. among others.